The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN)
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
Plus 2 other study approaches.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Jun 3, 2024 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Illinois at Chicago
- Interventions being studied
- Other: Educational Video about LDCT lung cancer screening; Other: A culturally tailored shared decision-making tool; Other: Flip chart; Other: Navigation support
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
1. Self-identify as African American or Black males 2. Current smokers of any nicotine-containing products 3. Do not self-report a history of lung cancer symptoms 4. Speaks English
1. Do not self-identify as African American males 2. Former smokers 3. Self-report a history of lung cancer symptoms 4. Do not speak English
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of IllinoisChicago, Illinois
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 3, 2024. Always confirm current availability with the study team.